Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that Norm Evans, Chief Financial Officer, is presenting at the 2014 Bloom Burton & Co. Healthcare Investor...

Cipher Pharmaceuticals Inc. (TSX: DND) ("the Company"), in accordance with Toronto Stock Exchange requirements, announced the voting results from its Annual General Meeting of Shareholders held...

Company achieves ninth consecutive quarter of profitability Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, May 2, 2014 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) today announced its...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced it will host a conference call for its Q1 2014 financial results and hold its Annual General Meeting of...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that Thomas G. Wellner has been appointed to the Board of Directors of the Company. Most recently, Mr. Wellner...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that Larry Andrews will be stepping down from his position as President and Chief Executive Officer. To ensure a...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and twelve months ended December 31, 2013. Fiscal 2013 Highlights Total revenue of $27.0...

Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q4 and Year-End 2013 financial results on Wednesday, February 26, 2014. Q4 and Year-End...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that Gerald (Gerry) McDole has been appointed as Chair of the Board of Directors of the Company effective...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that its marketing partner for Absoricaä has reached a cumulative sales milestone in accordance with the...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that William (Bill) Garriock has resigned from his position of Chair of Cipher, effective December 31, 2013, as...

Revenue increases to $5.6 million and earnings per share rise to $0.14 Toronto Stock Exchange Symbol: DND MISSISSAUGA,, ON, Oct. 30, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher")...

Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q3 2013 financial results on Wednesday, October 30, 2013. Q3 2013 CONFERENCE CALL WHEN:...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher") today announced that its sales and distribution partner, Ranbaxy Laboratories Inc. ("Ranbaxy") has received a Paragraph IV Certification Notice of...

Revenue increases to $5.5 million; Company records earnings per share of $0.13 Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 31, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND)...

Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q2 2013 financial results on Wednesday, July 31, 2013. Q2 2013 CONFERENCE CALL WHEN:...

At the 88th annual Canadian Dermatology Association Conference held in Quebec City over the July 1st weekend, Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher") announced the Canadian launch of...

- Revenue increases 82%, Company records earnings of $0.06 per share - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, May 3, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND); (OTC: CPHMF)...

Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) today announced it has entered into a definitive distribution and supply agreement with Tecnofarma International Ltd. ("Tecnofarma") under which...

Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) today announced it will host a conference call for its Q1 2013 financial results and hold its Annual and Special Meeting of Shareholders on...

- Revenue increases 137%, Company records earnings of $0.10 per share - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, March 1, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF)...

Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q4 and Year-End 2012 financial results on Friday, March 1, 2013. Q4 AND YEAR-END 2012...

Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), announced today that Larry Andrews, President and Chief Executive Officer, is presenting at Biotech Showcase™ 2013, which is being held in...

- Novel product provides valuable new treatment option for severe recalcitrant nodular acne - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Nov. 26, 2012 /CNW/ - Cipher Pharmaceuticals Inc....

Product to be launched as Epuris™ Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Nov. 20, 2012 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) announced today that Health Canada...